Galmed Pharmaceuticals
GLMD
GLMD
31 hedge funds and large institutions have $30.1M invested in Galmed Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
41% less capital invested
Capital invested by funds: $50.9M → $30.1M (-$20.8M)
Holders
31
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$705K | |
| 2 | +$671K | |
| 3 | +$154K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$109K |
| 5 |
WAM
Wealthspire Advisors (Maryland)
Potomac,
Maryland
|
+$65K |
Top Sellers
| 1 | -$7.14M | |
| 2 | -$4.69M | |
| 3 | -$572K | |
| 4 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$289K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$237K |